Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.4
Profusa, Inc. issued preferred stock to Bio Insights LLC for issuance of a newly created series of non-voting preferred stock designated as Series A Convertible Preferred Stock.
- Security
- preferred stock
- Purchaser
- Bio Insights LLC
- Consideration
- issuance of a newly created series of non-voting preferred stock designated as Series A Convertible Preferred Stock
Exact text from the filing
The offer and sale to Seller of the Securities will be made in reliance upon Section 4(a)(2) of the Securities Act of 1933
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Profusa, Inc. entered into Asset Purchase Agreement with Bio Insights LLC valued at $30,000,000 (effective 2026-04-21).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Bio Insights LLC
- Value
- $30,000,000
- Effective
- 2026-04-21
Exact text from the filing
On April 21, 2026, Profusa Inc., a Delaware corporation (the “ Company ”), and Bio Insights LLC, a limited liability company (“ Seller ”), entered into an Asset Purchase Agreement (the “ Asset Purchase Agreement ”) pursuant to which Seller agreed to sell, convey, assign, transfer, and deliver to the Company substantially all of the know-how assets relating to Seller’s PanOmics Assay
View on SEC.gov